Yayın:
Quercetin and Cisplatin combined treatment altered cell cycle and mitogen activated protein kinase expressions in malignant mesotelioma cells

dc.contributor.authorErgene, Emel
dc.contributor.authorSivas, Hülya
dc.contributor.authorNurettin Ayvali
dc.contributor.authorVictor Kuete
dc.contributor.authorHülya Sivas
dc.contributor.orcid0000-0001-6272-7158
dc.contributor.orcid0000-0002-5826-1305
dc.contributor.orcid0000-0002-1070-1236
dc.contributor.orcid0000-0002-8570-8328
dc.date.accessioned2025-11-13T10:06:44Z
dc.date.issued2016-08-11
dc.identifier.doihttps://doi.org/10.1186/s12906-016-1267-x
dc.identifier.endpage281
dc.identifier.issn1472-6882
dc.identifier.issue1
dc.identifier.openalexW2512385843
dc.identifier.startpage281
dc.identifier.urihttps://hdl.handle.net/11421/3156
dc.identifier.urihttps://doi.org/10.1186/s12906-016-1267-x
dc.identifier.volume16
dc.language.isoen
dc.relation.ispartofBMC Complementary and Alternative Medicine
dc.rightsopenAccess
dc.subjectCisplatin
dc.subjectMAPK/ERK pathway
dc.subjectCancer research
dc.subjectKinase
dc.subjectProtein kinase A
dc.subjectp38 mitogen-activated protein kinases
dc.subjectCell growth
dc.subjectCell cycle
dc.subjectMitogen-activated protein kinase
dc.subjectMedicine
dc.subjectChemistry
dc.subjectBiology
dc.subjectCell biology
dc.subjectCancer
dc.subjectInternal medicine
dc.subjectBiochemistry
dc.subjectChemotherapy
dc.subject.sdg3
dc.titleQuercetin and Cisplatin combined treatment altered cell cycle and mitogen activated protein kinase expressions in malignant mesotelioma cells
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5019014988
local.authorid.openalexA5051223501

Dosyalar

Koleksiyonlar